Bopindolol

Bopindolol (INN) is a beta blocker. It is an ester which acts as a prodrug for its active metabolite 4-(3-t-butylamino-2-hydroxypropoxy)-2-methylindole.[1]

Bopindolol

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	C07AA17 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name (RS)-1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl benzoate
CAS Number	69010-88-4^N
PubChem CID	44112
DrugBank	DB08807^Y
ChemSpider	40146^Y
UNII	KT304VZO57
KEGG	D07537^N
ChEMBL	ChEMBL357995^Y
CompTox Dashboard (EPA)	DTXSID6022684
Chemical and physical data
Formula	C23H28N2O3
Molar mass	380.488 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C3=CC=CC=C3
InChI InChI=1S/C23H28N2O3/c1-16-13-19-20(25-16)11-8-12-21(19)27-15-18(14-24-23(2,3)4)28-22(26)17-9-6-5-7-10-17/h5-13,18,24-25H,14-15H2,1-4H3^Y Key:UUOJIACWOAYWEZ-UHFFFAOYSA-N^Y
^NY (what is this?)  (verify)

See also

• Pindolol

References

1. Nagatomo T, Hosohata Y, Ohnuki T, Nakamura T, Hattori K, Suzuki J, Ishiguro M (Spring 2001). "Bopindolol: pharmacological basis and clinical implications". Cardiovasc Drug Rev. 19 (1): 9–24. doi:10.1111/j.1527-3466.2001.tb00180.x. PMID 11314603.